How to interpret her comments regarding another trial in regional hospitals? Would this expanded access be part of a potential Phase 3 trial or another Phase 2 trial treating a wider pool of stroke patients ie not only mechanical thrombectomy and/or possible preparation for label expansion should the drug be approved?
AGN Media thread, page-102
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
84.0¢ |
Change
0.025(3.07%) |
Mkt cap ! $103.2M | |||
| Open | High | Low | Value | Volume |
| 81.5¢ | 85.5¢ | 80.5¢ | $66.82K | 80.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 955 | 82.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 84.0¢ | 1028 | 2 |
View Market Depth
| Last trade - 14.17pm 08/08/2024 (20 minute delay) ? |
| AGN (ASX) Chart |